Morgan, Maxwell R. 2009. “Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism”. Science and Technology Law Review 11 (November). https://doi.org/10.7916/stlr.v11i0.3846.